Conference Coverage
Latest News
Videos
Advertisement
Shorts
0:18
Is 'Natural' Skincare Actually Better?
a day ago
by
Eileen Cheever, MPAS, PA-C
0:28
Stop Blaming Food for Acne: A Dermatologist Explains
2 days ago
by
Lisa Weiss, MMSc, PA-C
0:29
Stop Believing This Hair Washing Myth
3 days ago
by
Oyetewa Asempa, MD, FAAD
0:22
The #1 thing every medical professional needs
4 days ago
by
Justin Love, PA-C
0:23
A simple way for doctors to connect with patients
4 days ago
by
Victoria Garcia-Albea, NP
0:48
What I'd do if I won the lottery: Pediatric Derm Edition
5 days ago
by
Lisa Swanson, MD, FAAD
1:20
It Takes a Village: How Clinicians Can Support Patients With TSW
5 days ago
by
Renata Block, DMSc, MMS, PA-C(+1 more)
0:48
The Accutane Alternative You Need
6 days ago
by
Aaron S. Farberg, MD
0:53
Minimal Adverse Events Associated With Tapinarof Cream
6 days ago
by
Linda Stein Gold, MD
0:49
"Unscented" Isn't Fragrance-Free — Here's Why It Matters
7 days ago
by
Andrew C. Krakowski, MD(+1 more)
GEP-Guided Treatment for Melanoma & SCC Management
New Insights in Management of Moderate Hidradenitis Suppurativa
Discover Dermatology Times NP/PA Connect™!
Personalizing Treatment for Difficult Atopic Dermatitis Cases
Connect With Dermatology Times® Wherever You Scroll
Podcasts
Dermatology Times Digital Edition
Your Name Is on the Claim: Billing Compliance, Federal Enforcement, and Why the Provider Always Pays
In this edition of The Practice Playbook, learn incident-to rules, Mohs coding limits, NPI liability, and how audits and whistleblowers trigger FCA cases.
Learn more about the in-depth topics covered in the July 2026 digital issue of Dermatology Times.
In July's letter from the editor in chief, Christopher Bunick, MD, PhD, breaks down why dermatology clinicians should be skilled in wound care.
In this Cosmetics Conundrums column, learn why the cosmeceutical vehicle drives 80% of skin care results, shaping feel, film, and active delivery for visible benefits.
RAD 2026 experts unpacked new IL-13, JAK, STAT6 and OX40 options, CHE and pediatric gaps, plus overlooked comorbidities shaping AD care.
Jane Yoo, MD, MPP, FAAD, shares expert tips to treat melasma in skin of color regarding sunscreen shades, hydroquinone breaks, TXA choices, and safer laser/peel decisions.
Our July issue tackles melanoma surgery challenges, melasma in skin of color, new bemotrizinol sunscreen, atopic dermatitis breakthroughs, and billing insights from Whitney Hovenic, MD, Joseph Gatti, DMSc, Rivkah Epstein, PA-C, and more.
New trends around cheeky swimwear and tanning myths are leading to rising rates of melanomas in sensitive areas; read July's cover story to learn more.
Learn more about the in-depth topics covered in the June 2026 print issue of Dermatology Times.
Lim considers mentoring and helping develop the next generation of dermatologists one of his most meaningful contributions to the specialty.
Continuing Medical Education
All News
Advertisement
Advertisement
Your Name Is on the Claim: Billing Compliance, Federal Enforcement, and Why the Provider Always Pays
In this edition of The Practice Playbook, learn incident-to rules, Mohs coding limits, NPI liability, and how audits and whistleblowers trigger FCA cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Catch Up on Coverage From Day 5 of the 3rd Annual Elevate-Derm Summer Conference
As we wrap up UV Safety Awareness Month, Kathleen Suozzi, MD, explains warning signs of sun damage, sunscreen myths, and new year-round protection tools—plus the newly FDA-approved bemotrizinol.
Catch Up on Coverage From Day 4 of the 3rd Annual Elevate-Derm Summer Conference
Catch Up on Coverage From Day 3 of the 3rd Annual Elevate-Derm Summer Conference
Faculty at Elevate-Derm Summer 2026 discussed the expanding role of oral JAK inhibitors in pediatric dermatology, emphasizing earlier intervention, individualized patient selection, safety monitoring, and family-centered counseling.
Learn more about the in-depth topics covered in the July 2026 digital issue of Dermatology Times.
In July's letter from the editor in chief, Christopher Bunick, MD, PhD, breaks down why dermatology clinicians should be skilled in wound care.
Catch Up on Coverage From Day 2 of the 3rd Annual Elevate-Derm Summer Conference
Advertisement
Two phase 3 trials of Pfizer's ritlecitinib met co-primary end points for facial and total repigmentation in nonsegmental vitiligo at week 52, prompting plans for global regulatory filings.
In this Cosmetics Conundrums column, learn why the cosmeceutical vehicle drives 80% of skin care results, shaping feel, film, and active delivery for visible benefits.
RAD 2026 experts unpacked new IL-13, JAK, STAT6 and OX40 options, CHE and pediatric gaps, plus overlooked comorbidities shaping AD care.
Jane Yoo, MD, MPP, FAAD, shares expert tips to treat melasma in skin of color regarding sunscreen shades, hydroquinone breaks, TXA choices, and safer laser/peel decisions.
Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
Advertisement
Advertisement
Trending on Dermatology Times
1
Navigating UV Safety, Photodamage, and Next-Gen Protection: A Q&A With Kathleen Suozzi, MD
2
Dermatology NP Highlights Emerging Therapies and Patient Trust at Elevate-Derm
3
FDA Accepts sBLA for OnabotulinumtoxinA in Masseter Muscle, Pursuing Fifth Aesthetic Indication
4
Elevate-Derm Faculty Highlight Expanding Role of Oral JAK Inhibitors in Pediatric Dermatology
5